\u0130la\u00e7 End\u00fcstrisi \u0130\u015fverenleri Sendikas\u0131 Ba\u015fkan\u0131 Nezih Barut, “DS\u00d6’n\u00fcn tahminlerine g\u00f6re, ila\u00e7lar\u0131n y\u00fczde 50’sinden fazlas\u0131 uygun olmayan \u015fekilde re\u00e7etelenmekte, temin edilmekte ve sat\u0131lmaktad\u0131r” dedi.<\/p>\n
<\/p>\n
Ayn\u0131 zamanda Abdi \u0130brahim \u0130la\u00e7 Sanayi Ba\u015fkan\u0131 da olan Barut, yanl\u0131\u015f, gereksiz, etkisiz ve y\u00fcksek maliyetli ila\u00e7 kullan\u0131m\u0131 sonucunda, hastal\u0131k ve \u00f6l\u00fcm oranlar\u0131nda y\u00fckselme, yan etki riskinin artmas\u0131, temel ila\u00e7lara ula\u015f\u0131labilirli\u011fin azalmas\u0131 ve ila\u00e7lara kar\u015f\u0131 geli\u015febilecek dirence dayal\u0131 tedavi maliyetinin artmas\u0131 gibi sorunlarla kar\u015f\u0131la\u015f\u0131labilece\u011fini s\u00f6yledi.<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n <\/p>\n Barut, T\u00fcrkiye’de yanl\u0131\u015f ve gereksiz ila\u00e7 kullan\u0131m\u0131n\u0131n halk sa\u011fl\u0131\u011f\u0131n\u0131 etkileyen \u00f6nemli bir halk sa\u011fl\u0131\u011f\u0131 sorunu oldu\u011funu dile getirdi. Topluma ak\u0131lc\u0131 ila\u00e7 kullan\u0131m\u0131 al\u0131\u015fkanl\u0131\u011f\u0131n\u0131n kazand\u0131r\u0131lmas\u0131nda, hangi ilac\u0131n kullan\u0131laca\u011f\u0131na karar veren hekim, ilac\u0131n kullan\u0131m\u0131na dair dan\u0131\u015fmanl\u0131k hizmeti veren eczac\u0131, ilac\u0131 \u00fcreten \u015firketler, sa\u011fl\u0131k otoriteleri ve hastalar\u0131n ortak sorumluluk ta\u015f\u0131d\u0131\u011f\u0131n\u0131n alt\u0131n\u0131 \u00e7izen Barut, bu sorumluluk \u00e7er\u00e7evesinde de\u011ferlendirildi\u011finde, son y\u0131llarda sa\u011fl\u0131k hizmetlerine eri\u015fimin artm\u0131\u015f olmas\u0131na ra\u011fmen, ila\u00e7 kullan\u0131m\u0131 konusunda fark\u0131ndal\u0131k ve bilin\u00e7 d\u00fczeyinde ayn\u0131 olumlu tabloyu g\u00f6rmenin m\u00fcmk\u00fcn olmad\u0131\u011f\u0131n\u0131 ifade etti.<\/p>\n <\/p>\n Barut, “ilac\u0131n gereksiz kullan\u0131m\u0131 sonucunda, doktor taraf\u0131ndan re\u00e7etelenmeden ve eczac\u0131ya dan\u0131\u015f\u0131lmadan \u00fc\u00e7\u00fcnc\u00fc \u015fah\u0131slar\u0131n tavsiyesi ya da bilimsel olmayan duyumlar ile t\u00fcketilmesi gibi s\u0131k\u0131nt\u0131lar\u0131n \u00f6n plana \u00e7\u0131kt\u0131\u011f\u0131n\u0131” bildirdi.<\/p>\n <\/p>\n <\/p>\n “\u0130LA\u00c7 END\u00dcSTR\u0130S\u0130 B\u0130L\u0130N\u00c7L\u0130 \u0130LA\u00c7 KULLANIMININ YAYGINLA\u015eMASINA DESTEK OLMALI”<\/p>\n
\nBu kapsamda, d\u00fcnyada ilac\u0131n bilin\u00e7li kullan\u0131lmas\u0131 amac\u0131yla \u00e7e\u015fitli \u00e7\u00f6z\u00fcm yollar\u0131 \u00fcretilmeye ve geli\u015ftirilmeye \u00e7al\u0131\u015f\u0131ld\u0131\u011f\u0131n\u0131 ve ilk kez D\u00fcnya\u00a0Sa\u011fl\u0131k<\/a>\u00a0\u00d6rg\u00fct\u00fc (DS\u00d6) taraf\u0131ndan “Ak\u0131lc\u0131 \u0130la\u00e7 Kullan\u0131m\u0131” \u00e7al\u0131\u015fmalar\u0131 ba\u015flat\u0131ld\u0131\u011f\u0131n\u0131 anlatan Barut, “DS\u00d6’n\u00fcn tahminlerine g\u00f6re, ila\u00e7lar\u0131n y\u00fczde 50’sinden fazlas\u0131 uygun olmayan \u015fekilde re\u00e7etelenmekte, temin edilmekte ve sat\u0131lmaktad\u0131r” dedi.<\/p>\n